Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers
Laksshman Sundaram(Illumina (United States)), Benjamin K. Johnson(Van Andel Institute), M. Ryan Corces(Gladstone Institutes), Neal G. Ravindra(Xalud Therapeutics (United States)), Matthew Myers(Memorial Sloan Kettering Cancer Center), Shahab Sarmashghi(Broad Institute), Bradley M. Broom, Ina Felau(National Cancer Institute), Kyle Kai‐How Farh(Illumina (United States)), Peter W. Laird(Van Andel Institute), Benjamin J. Raphael(Princeton University), John N. Weinstein(The University of Texas MD Anderson Cancer Center), Toshinori Hinoue(University of Southern California), Roy Tarnuzzer(University of Central Florida), Andrew D. Cherniack(Broad Institute), Shadi Shams(Stanford University), Won-Young Choi(University of Tennessee Health Science Center), Jeffrey M. Granja(Enable Biosciences (United States)), John A. Demchok(National Cancer Institute), Howard Y. Chang(Stanford University), Alexander J. Lazar(The University of Texas MD Anderson Cancer Center), Andrew McPherson(University of British Columbia), Ashley S. Doane, Hani Choudhry(King Abdulaziz University), Brian H. Louie(Memorial Sloan Kettering Cancer Center), Yanding Zhao(Stanford University), Rehan Akbani(The University of Texas MD Anderson Cancer Center), Christopher K. Wong(University of California, Santa Cruz), Mauro A. A. Castro(Universidade Federal do Paraná), William J. Greenleaf(Stanford University), D. Neil Hayes(University of North Carolina at Chapel Hill), Kathryn E. Yost(Whitehead Institute for Biomedical Research), Rojin Safavi(University of California, Santa Cruz), S. Tansu Bagdatli(Stanford University), Liming Yang(China Three Gorges Corporation (China)), Zhining Wang(Shandong University), Shwetha V. Kumar(The University of Texas MD Anderson Cancer Center), Arvind Kumar(Illumina (United States)), Adriana Salcedo(Illumina (United States)), Hyo Young Choi(University of Tennessee Health Science Center), Ekta Khurana(The University of Texas MD Anderson Cancer Center), Jean C. Zenklusen(National Cancer Institute)
Cited by 53
Related Papers
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.5k
The Immune Landscape of Cancer
|Immunity|2018|6.2k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k